Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal?

Unresectable or relapsed hepato-cellular carcinomas

Date

29 Sep 2019

Session

ESMO Colloquium supported by Lilly Oncology - Metastatic gastro-intestinal cancer: Multiple treatment lines, extended pipeline of available drugs and use of predictive markers. How to best sequence the treatment proposal?

Topics

Cytotoxic Therapy

Tumour Site

Hepatobiliary Cancers

Presenters

Jean-Luc Raoul

Authors

J. Raoul

Author affiliations

Medical Oncology Department, ICO Institut de Cancerologie de l'Ouest René Gauducheau, 44805 - Saint-Herblain/FR

Resources

If you do not have an ESMO account, please create one for free.

Resources from the same session